(FILES) (L/R) US Secretary of Health and Human Services Robert F. Kennedy Jr., Food and Drug Administration (FDA) Commissioner Martin Makary and President Donald Trump attend an announcement event on prescription drugs in the Oval Office of the White House in Washington, DC, on September 30, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Brendan SMIALOWSKI / AFP via Getty Images)

(FILES) (L/R) Food and Drug Administration (FDA) Commissioner Martin Makary speaks alongside US Secretary of Health and Human Services Robert F. Kennedy Jr. during the daily briefing in the Brady Briefing Room of the White House in Washington, DC, on January 7, 2026. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Mandel NGAN / AFP via Getty Images)

(FILES) FDA Commissioner Marty Makary (2L) speaks before US President Donald Trump signs an executive order in the Oval Office of the White House in Washington, DC on April 18, 2026. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Jim WATSON / AFP via Getty Images)

(FILES) (L/R) Food and Drug Administration (FDA) Commissioner Martin Makary and US President Donald Trump look on during an event about autism in the Roosevelt Room of the White House in Washington, DC on September 22, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by SAUL LOEB / AFP via Getty Images)

(FILES) US Food and Drug Administration (FDA) Commissioner Martin Makary testifies at an Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee hearing on "A Review of the President's FY2026 Budget Request for the Food and Drug Administration" on Capitol Hill in Washington, DC, on May 22, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by Drew ANGERER / AFP via Getty Images)

(FILES) Food and Drug Administration (FDA) Commissioner Dr. Marty Makary speaks alongside US Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., as they announce the sending of warning letters to companies for illegally marketing products containing 7-hydroxymitragynine, also known as 7-OH, as part of their actions combatting opioids, during a press conference at HHS headquarters in Washington, DC, on July 29, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by SAUL LOEB / AFP via Getty Images)

(FILES) Food and Drug Administration (FDA) Commissioner Dr. Marty Makary speaks about the sending of warning letters to companies for illegally marketing products containing 7-hydroxymitragynine, also known as 7-OH, as part of their actions combatting opioids, during a press conference at HHS Headquarters in Washington, DC, July 29, 2025. President Donald Trump said on May 12, 2026, his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes. (Photo by SAUL LOEB / AFP via Getty Images)

WASHINGTON, DC - MAY 12: U.S. President Donald Trump speaks in front of the American flag to the press as he departs the White House on May 12, 2026 in Washington, DC. Trump is traveling to China where he is scheduled to meet with Chinese President Xi Jinping for expected talks on the Iran conflict, trade imbalances, regional security, and economic cooperation between the two countries. (Photo by Kevin Dietsch/Getty Images)